Gilead Drops After Remdesivir Antivirus Drug 'Flopped' In Trials

Gilead drops after Remdesivir antivirus drug 'flopped' in trials

CNBC Television

Gilead halted after medication Remdesivir flopped in coronavirus trial

CNBC Television

Gilead terminates study after coronavirus drug Remdesivir fails to improve recovery for COVID-19

Gilead Drug Flops In First Trial

Gilead Covid-19 Drug Remdesivir Fails in Chinese Trial

Bloomberg Television

What you need to know about Gilead's 'flopped' Remdesivir drug trial

CNBC Television

Remdesivir treatment for Covid-19: New Drug Review. Veklury coronavirus antiviral from Gilead.

The PharmEZ Tutor

Fauci: Gilead's Remdesivir Drug Trials Show ‘Good News' Against Covid-19 Fight

Bloomberg Quicktake

Gilead CEO on promising study results for remdesivir Covid-19 treatment

CNBC Television

Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'

NIAID trial of remdesivir met its 'primary goal': Gilead

CNBC Television

Gilead's Virus Drug Remdesivir Gains Approval From FDA

Bloomberg Television

Gilead Working to Maximize Remdesivir Access

Bloomberg Television

Gilead To Test Inhaled Version Of Remdesivir

FOX 5 San Diego

All you need to know about Gilead's Remdesivir

Gilead reports 'positive data' on Remdesivir coronavirus drug trial

CNBC Television

Gilead Sciences Confirms Breakthrough In Anti-COVID Drug Remdesivir

NDTV

Gilead Drug Remdesivir Is a Rare Example of Foresight in the Coronavirus Pandemic

Bloomberg Quicktake

U.S. Biotech Firm Gilead Reports Successful Results For COVID-19 Drug Trial

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment